Gene · 6781
Papers1,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineered atopic dermatitis models for recreating hypoxic conditions in atopic dermatitis microenvironments. | Bioact Mater | 2026 | 41551767 | PubTator, text mining | PubMed |
| Single-cell profiling defines the cellular landscape of the urinary bladder: a scoping review. | Eur J Med Res | 2026 | 41491261 | PubTator, text mining | PubMed |
| Lactylation-driven NSUN2-mediated RNA m5C modification promotes perineural invasion in pancreatic cancer. | Theranostics | 2026 | 41356184 | PubTator, text mining | PubMed |
| Systematic Pan-Cancer Analysis of the Oncogenic and Immunological Function of Stanniocalcin-1 (STC1). | Curr Med Chem | 2026 | 40525442 | PubTator, text mining | PubMed |
| From a Fish Protein to a Novel Glaucoma Therapeutic: Stanniocalcin-1 for Intraocular Pressure Reduction. | Adv Ophthalmol Optom | 2025 | 42756961 | PubTator, text mining | PubMed |
| Macrophage-centered therapy strategies: A promising weapon in cancer immunotherapy. | Asian J Pharm Sci | 2025 | 41809255 | PubTator, text mining | PubMed |
| Spatial and Bulk Transcriptomics Reveal Distinct Molecular Signatures in Kaposi Sarcoma with and Without other KSHV-Associated Diseases. | medRxiv | 2025 | 41409683 | PubTator, text mining | PubMed |
| Spatial Transcriptomics of Patients With Kaposi Sarcoma Identifies Mechanisms of Immune Evasion. | J Med Virol | 2025 | 41342328 | PubTator, text mining | PubMed |
| FTO Modulates m6A RNA Methylation of STC1 to Regulate Inflammation and Oxidative Stress in Diabetic Nephropathy. | FASEB J | 2025 | 41335031 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps-STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancer. | J Immunother Cancer | 2025 | 41314976 | PubTator, text mining | PubMed |
| A novel tumor microenvironment-related gene signature for prognostic prediction of intrahepatic cholangiocarcinoma. | Sci Rep | 2025 | 41285867 | PubTator, text mining | PubMed |
| MSCs ameliorates hyperglycemia-induced endothelial injury through modulation of mitochondrial dynamics. | Cell Death Dis | 2025 | 41249792 | PubTator, text mining | PubMed |
| Letter to editor: AAV-mediated STC-1 expression mitigates neuroinflammation and preserves visual function in degenerative retinopathy. | J Transl Med | 2025 | 41225480 | PubTator, text mining | PubMed |
| METTL3: A dual regulator of oral tissue regeneration and malignancy with therapeutic implications for stem cell therapy and chemoresistance. | Sci Prog | 2025 | 41118452 | PubTator, text mining | PubMed |
| STC1 downregulation promotes ferroptosis in human brain microvascular endothelial cells: implications for moyamoya disease pathogenesis. | Neuroscience | 2025 | 41077114 | PubTator, text mining | PubMed |
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. | J Immunother Cancer | 2025 | 41052886 | PubTator, text mining | PubMed |
| STC1-Based Activation of NF-κB Signaling Pathway Induces Epthithelial-Mesenchymal Transition Thus Promotes Progression and Temozolomide Resistance of Glioblastoma. | FASEB J | 2025 | 41020346 | PubTator, text mining | PubMed |
| Measuring the Senescence-Associated Secretory Phenotype. | Biomedicines | 2025 | 41007626 | PubTator, text mining | PubMed |
| Enhanced disc regeneration through CRISPR/Cas9-mediated SOX9 and TGFβ1 coexpression in tonsil-derived mesenchymal stromal cells. | Stem Cell Res Ther | 2025 | 40999513 | PubTator, text mining | PubMed |
| Comprehensive profiling of activity and specificity of RNA-guided transposons reveals opportunities to engineer improved variants. | Nucleic Acids Res | 2025 | 40985776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6781/papers?page=3